TOMI Regains Nasdaq Compliance Effective November 12 and Faces One Year of Monitoring
Key Facts
TOMI Environmental Solutions announced on November 17 that it had regained compliance, effective November 12, with Nasdaq’s minimum closing bid price and stockholders’ equity requirements. The company’s shares will continue to be listed on the Nasdaq Capital Market under the symbol TOMZ. The decision, however, does not end the conditions for continued listing; the company said its status will remain subject to conditions and monitoring by the Nasdaq Hearings Panel. Among those conditions is providing the panel with detailed information on anticipated actions, including financing under consideration. Continued listing is therefore tied to compliance monitoring and the actions requested by the panel.
Under the disclosure filed with the U.S. Securities and Exchange Commission, TOMI will be subject to discretionary monitoring by the Hearings Panel for one year beginning September 2, 2026. During this period, any subsequent violation of the stockholders’ equity requirement will result in immediate delisting. A violation of any other Nasdaq requirement would require the company to submit a plan to regain compliance to the panel within 7 calendar days. These provisions make clear that regaining compliance now does not exempt the company from the consequences of any subsequent breach. The plan deadline applies to other violations, while a repeat violation of the stockholders’ equity requirement carries a more severe consequence.
The background to the matter dates to notices TOMI received from Nasdaq on November 21, 2025, May 20, 2026, and September 2, 2026, regarding noncompliance with the minimum bid price and minimum stockholders’ equity requirements. TOMI said the Hearings Panel granted its request to continue its listing subject to conditions, including providing details on anticipated actions and financing under consideration. These conditions cover the two tracks the company pursued to regain compliance and specify what it must submit to the panel. In its announcement, the company confirmed that its shares will continue to trade on the Nasdaq Capital Market under the symbol TOMZ, with continued listing still subject to monitoring. The decision therefore remains tied to compliance with market requirements and the conditions set by the Hearings Panel.
The compliance announcement came after the company reported on November 12 that third-quarter 2026 revenue had risen to 2,492,801 dollars, up 24% from 2,011,556 dollars in the third quarter of 2025 and 11% from 2,246,909 dollars in the second quarter of 2026. For the nine months ended September 30, TOMI said revenue increased 38% to 6,393,937 dollars, compared with 4,619,229 dollars in the corresponding period of 2025. The figures provide operating context for the regulatory news as the company works to convert its backlog and sales pipeline into revenue. The company had described its third-quarter results as preliminary in its financial announcement. The compliance announcement did not link revenue growth to Nasdaq’s conditions, which remain in place independently.
In its financial update, TOMI said its backlog stood at about 2.5 million dollars on September 30 and later rose to about 2.8 million dollars. The company estimated its total sales pipeline at about 35 million dollars, with about 25% in advanced stages. The chief executive said the focus includes converting backlog and sales opportunities, expanding recurring revenue through the SteraMist platform, and developing initiatives in the food safety, life sciences, and defense sectors. According to the company, it is relying on converting commercial opportunities into revenue and increasing recurring sales to support growth. These priorities remain separate from the listing requirements and monitoring imposed by the Nasdaq Hearings Panel.
In trading on November 17, EL7 data showed TOMZ closing at 2.27 dollars, compared with a close of 2.45 dollars in the previous session, November 16. The close came on the day the company announced it had regained compliance, but does not change the continued-listing conditions announced by TOMI. During the monitoring period, the company will remain required to comply with Nasdaq requirements; if it again violates the stockholders’ equity requirement during the period, the disclosure provides for immediate delisting. If it violates another requirement, it must submit a plan to the Hearings Panel within 7 calendar days. The panel’s decisions and the actions the company submits remain critical to TOMZ’s listing status.